Resources
Norton Healthcare Services
Learn more about Norton Healthcare services and resources for providers
Norton Children's Services
Learn more about Norton Children's services and resources for providers
Continuing Medical Education
CME opportunities for pediatric and adult care
Resource page
Provider Spotlight
David A. Robertson, M.D.
David A. Robertson, M.D., neurologist and neuroimmunologist, is helping to expand neurologic care for adults with physical and intellectual disabilities.
Norton Neuroscience Institute selected to pilot national Brain Health Navigator program
Norton Neuroscience Institute is one of six sites nationwide chosen to pilot a new Brain Health Navigator program aimed at creating a worldwide model to prevent, diagnose and treat Alzheimer’s disease. The program — funded […]
Read Full Story
January 2025 Norton Children’s Medical Group New Providers
Emily J Allen, DO Pediatric Hospital Medicine Alyssa N Conley Hamlin, DO Pediatric Hospital Medicine Virginia Menche, M.D. Pediatrics Nicholas Miles, M.D. Child Abuse Pediatrics Tea Stanfield, APRN Pediatric Emergency Medicine Dylan P Vish, MD […]
Read Full Story
January 2025 Norton Medical Group new providers
Sirmad B. Chaudhary, M.D. Internal Medicine Gregory L. Fuqua, M.D. Family Medicine Megan E. Gruber, D.O. Electrophysiology Loretta L. Jophlin, M.D., Ph.D. Gastroenterology Kenneth Cox, CSFA General Surgery Brittani D’Angelo, PA-C Pulmonology Ashley B. Hartin, […]
Read Full Story
Electrophysiologist brings connection, empathy and a tailored approach to her practice
According to the American Heart Association, cardiovascular disease remains the leading cause of death in women. Approximately 1 in 4 women will develop atrial fibrillation (AF), and women with AF are at greater risk for […]
Read Full Story
Treating side effects and other lessons learned while administering Alzheimer’s drug lecanemab
A recent study published in the The Journal of Prevention of Alzheimer’s Disease provides detailed insight into clinicians’ and patients’ initial experience with lecanemab, the first Food and Drug Administration-approved antiamyloid monoclonal antibody infusion proven [...]
Read Full Story